FDA.reportPublic FDA data

0.2 ML glucagon 5 MG/ML Auto-Injector [Gvoke]

RxCUI
2199308
RxNorm name
0.2 ML glucagon 5 MG/ML Auto-Injector [Gvoke]
Display name
0.2 ML glucagon 5 MG/ML Auto-Injector [Gvoke]
Full name
0.2 ML glucagon 5 MG/ML Auto-Injector [Gvoke]
Term type
SBD
Status
DailyMed mapping
Updated
2026-06-04 23:39:08

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
92385737-dbad-98c5-e053-2995a90a2805Gvoke HypoPen 1 MG in 0.2 mL Auto-Injector [PSN] · 0.2 ML glucagon 5 MG/ML Auto-Injector [Gvoke] [SBD] · 0.2 ML Gvoke 5 MG/ML Auto-Injector [SY] · Gvoke HypoPen 1 MG per 0.2 mL Auto-Injector [SY]420These highlights do not include all the information needed to use GVOKE and GVOKE VialDx safely and effectively. See full prescribing information for GVOKE and GVOKE VialDx. GVOKE (glucagon) injection, for subcutaneous use GVOKE VialDx (glucagon) injection, for intravenous use Initial U.S. Approval: 196020251223